Composition
- Active ingredients
- KANAMYCIN SULFATE EQ 75MG BASE/2ML
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- KANAMYCIN SULFATE EQ 75MG BASE/2ML · InjectableANDA061655-003 · Discontinued
- KANAMYCIN SULFATE EQ 500MG BASE/2ML · InjectableANDA061655-001 · Discontinued
- KANAMYCIN SULFATE EQ 1GM BASE/3ML · InjectableANDA061655-002 · Discontinued
- KANAMYCIN SULFATE EQ 75MG BASE/2ML · InjectableThis page
- KANAMYCIN SULFATE EQ 500MG BASE/2ML · InjectableANDA061901-001 · Discontinued
- KANAMYCIN SULFATE EQ 1GM BASE/3ML · InjectableANDA061901-002 · Discontinued
- KANAMYCIN SULFATE EQ 1GM BASE/3ML · InjectableANDA062564-003 · Discontinued
- KANAMYCIN SULFATE EQ 75MG BASE/2ML · InjectableANDA062564-001 · Discontinued
- KANAMYCIN SULFATE EQ 500MG BASE/2ML · InjectableANDA062564-002 · Discontinued
- KANAMYCIN SULFATE EQ 500MG BASE · CapsuleANDA061911-001 · Discontinued
- KANAMYCIN SULFATE EQ 500MG BASE · CapsuleANDA060516-001 · Discontinued
- KANAMYCIN SULFATE EQ 500MG BASE · CapsuleANDA062726-001 · Discontinued
At a glance
- Brand name
- Kantrex
- Active substance
- kanamycin sulfate
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Apothecon
- Status
- Discontinued
- FDA approval
- 6 Mar 1975
- Application
- ANDA061901-003